Acquired Company
XOMA Royalty Corporation (NASDAQ: XOMA) has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR”).
Turnstone Biologics Corp. operates as a biotechnology company. The company was founded in 2014 and is headquartered in San Diego, California. As of August 11, 2025, Turnstone Biologics Corp. operates as a subsidiary of XOMA Royalty Corporation. Show more
9310 Athena Circle, San Diego, CA, 92037, United States
Market Cap
8.215M
52 Wk Range
$0.29 - $0.78
Previous Close
$0.36
Open
$0.36
Volume
N/A
Day Range
$0.36 - $0.36
Enterprise Value
-8.062M
Cash
16.69M
Avg Qtr Burn
-11.36M
Insider Ownership
7.70%
Institutional Own.
51.49%
Qtr Updated
06/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
TIDAL-01 Details Colorectal cancer , Breast cancer, Uveal melanoma | Failed Discontinued |